A doctor discusses common issues and questions around Foundayo, the oral obesity pill approved by the FDA this week.

Novel OCTA metrics show conbercept loading injections enhance microvascular perfusion and complexity in proliferative diabetic retinopathy.

You can now choose between GLP-1 pills or shots for weight loss. Here's what you need to know to decide which one is best for ...

This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, ...

The daily pill, called Foundayo, follows the approval of Novo Nordisk's Wegovy pill in recent months. The lowest dose is ...

The southern Africa country has the world’s highest prevalence of HIV but the amount of lenacapavir reaching it is too small to reach all those at risk ...

Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill ...

Wegovy pill, from Novo Nordisk, was the first oral GLP-1 drug to be approved by the FDA, in December 2025. Foundayo is the ...

Bicara Therapeutics is well-capitalized, with over $414.8M in cash and funding runway into H1 2029, but faces competitive ...

The FDA has approved a higher-dose regimen of Spinraza for spinal muscular atrophy, providing a new treatment option for patients. The regimen includes 50 milligram per 5 milliliter and 28 milligram ...

Shares of Biogen BIIB rose 2% on Monday after the company announced that the FDA approved a higher dose of its blockbuster ...

The Muscular Dystrophy Association (MDA) celebrates today's announcement that the U.S. Food and Drug Administration (FDA) has approved a High Dose Regimen of SPINRAZA(R) (nusinersen) for the treatment ...